Average Co-Inventor Count = 4.70
ph-index = 4
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Hetero Research Foundation (49 from 49 patents)
2. Hetero Drugs Limited (35 from 45 patents)
3. Hetero Labs Limited (6 from 15 patents)
4. Honour (r&d) (3 from 3 patents)
5. Hetero Research Foundation, Hetero Drugs Limited (2 from 2 patents)
6. Other (1 from 832,680 patents)
7. Dfh Therapeutics, Inc. (1 from 2 patents)
96 patents:
1. 11434206 - Process for the preparation of diphenylpyrazine derivatives
2. 11053211 - Process for pomalidomide
3. 11034718 - C-3 novel triterpenone with C-17 reverse amide derivatives as HIV inhibitors
4. 10934251 - Process for the preparation of lomitapide
5. 10822314 - Process for the preparation of a dual-acting angiotensin receptor-neprilysin inhibitor compound
6. 10815204 - Process for the preparation of diphenylpyrazine derivatives
7. 10562867 - Process for the preparation of a dual-acting angiotensin receptor-neprilysin inhibitor compound
8. 10533035 - C-3 novel triterpenone with C-17 reverse amide derivatives as HIV inhibitors
9. 10464931 - Process for the preparation of Quinolin-2(1H)-one derivatives
10. 10442769 - Process for the preparation of intermediate of dolutegravir
11. 10336706 - Crystalline form of Eltrombopag free acid
12. 10329281 - Polymorphs and process for the preparation of quinazolinyl derivatives
13. 10214497 - Process for the preparation of a dual-acting angiotensin receptor-neprilysin inhibitor compound
14. 10206874 - Rufinamide solid dispersion
15. 10023526 - Process for the preparation of lomitapide